<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1" />

<meta name="author" content="Assaf Oron" />

<meta name="date" content="2022-07-02" />

<title>Vignette for ‘cir’ Package</title>

<script>// Pandoc 2.9 adds attributes on both header and div. We remove the former (to
// be compatible with the behavior of Pandoc < 2.8).
document.addEventListener('DOMContentLoaded', function(e) {
  var hs = document.querySelectorAll("div.section[class*='level'] > :first-child");
  var i, h, a;
  for (i = 0; i < hs.length; i++) {
    h = hs[i];
    if (!/^h[1-6]$/i.test(h.tagName)) continue;  // it should be a header h1-h6
    a = h.attributes;
    while (a.length > 0) h.removeAttribute(a[0].name);
  }
});
</script>

<style type="text/css">
  code{white-space: pre-wrap;}
  span.smallcaps{font-variant: small-caps;}
  span.underline{text-decoration: underline;}
  div.column{display: inline-block; vertical-align: top; width: 50%;}
  div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  ul.task-list{list-style: none;}
    </style>



<style type="text/css">
  code {
    white-space: pre;
  }
  .sourceCode {
    overflow: visible;
  }
</style>
<style type="text/css" data-origin="pandoc">
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { display: inline-block; line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
  { counter-reset: source-line 0; }
pre.numberSource code > span
  { position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
  { content: counter(source-line);
    position: relative; left: -1em; text-align: right; vertical-align: baseline;
    border: none; display: inline-block;
    -webkit-touch-callout: none; -webkit-user-select: none;
    -khtml-user-select: none; -moz-user-select: none;
    -ms-user-select: none; user-select: none;
    padding: 0 4px; width: 4em;
    color: #aaaaaa;
  }
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa;  padding-left: 4px; }
div.sourceCode
  {   }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } /* Alert */
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } /* Annotation */
code span.at { color: #7d9029; } /* Attribute */
code span.bn { color: #40a070; } /* BaseN */
code span.bu { } /* BuiltIn */
code span.cf { color: #007020; font-weight: bold; } /* ControlFlow */
code span.ch { color: #4070a0; } /* Char */
code span.cn { color: #880000; } /* Constant */
code span.co { color: #60a0b0; font-style: italic; } /* Comment */
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } /* CommentVar */
code span.do { color: #ba2121; font-style: italic; } /* Documentation */
code span.dt { color: #902000; } /* DataType */
code span.dv { color: #40a070; } /* DecVal */
code span.er { color: #ff0000; font-weight: bold; } /* Error */
code span.ex { } /* Extension */
code span.fl { color: #40a070; } /* Float */
code span.fu { color: #06287e; } /* Function */
code span.im { } /* Import */
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } /* Information */
code span.kw { color: #007020; font-weight: bold; } /* Keyword */
code span.op { color: #666666; } /* Operator */
code span.ot { color: #007020; } /* Other */
code span.pp { color: #bc7a00; } /* Preprocessor */
code span.sc { color: #4070a0; } /* SpecialChar */
code span.ss { color: #bb6688; } /* SpecialString */
code span.st { color: #4070a0; } /* String */
code span.va { color: #19177c; } /* Variable */
code span.vs { color: #4070a0; } /* VerbatimString */
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } /* Warning */

</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    for (var j = 0; j < rules.length; j++) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") continue;
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') continue;
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>




<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; } 
code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">Vignette for ‘cir’ Package</h1>
<h3 class="subtitle">Using Up-and-Down data from Benhamou et
al. (2004)</h3>
<h4 class="author">Assaf Oron</h4>
<h4 class="date">2022-07-02</h4>



<div id="background" class="section level2">
<h2>Background</h2>
<p>We demonstrate the <code>cir</code> package with data from the
anesthesiology experiment of Benhamou et al.<a href="#fn1" class="footnote-ref" id="fnref1"><sup>1</sup></a>. This experiment used
the Up-and-Down (UD) dose-finding design, and was re-analyzed a few
years later by Pace and Stylianou.<a href="#fn2" class="footnote-ref" id="fnref2"><sup>2</sup></a> Here we re-analyze them again using
state-of-the-art Centered Isotonic Regression (CIR),<a href="#fn3" class="footnote-ref" id="fnref3"><sup>3</sup></a> the core estimator
found in our package.</p>
<p>The study randomized women in labor into two groups, receiving as
analgesic either ropivacaine or levobupivacaine, to estimate each
agent’s median effective dose (ED<span class="math inline">\(_{50}\)</span>) for this condition, and test
whether they are different. The original study used a “traditional”
dose-averaging estimation method, concluding that even though
levobupivacaine seemed 19% more potent, the difference between ED<span class="math inline">\(_{50}\)</span>’s, and hence the difference in
potency, was not significant. To derive inference about this difference,
they apparently used the standard errors of the dose averages in a <span class="math inline">\(t\)</span>-test like manner.</p>
<p>Pace and Stylianou re-analyzed the data using isotonic regression
(IR) and 83% bootstrap confidence intervals (CIs); under certain
assumptions, examining whether these CIs overlap is equivalent to
rejecting the Null hypothesis. <a href="#fn4" class="footnote-ref" id="fnref4"><sup>4</sup></a> They found a larger and statistically
significant difference between the two ED<span class="math inline">\(_{50}\)</span>’s. Per their estimates,
levobupivacaine was 37% more potent.</p>
<p>Here we revisit this experiment yet again.</p>
</div>
<div id="experimental-trajectories" class="section level2">
<h2>Experimental Trajectories</h2>
<p>Since UD datasets are rather compact, adding the data takes no more
than 2-3 lines of code. But you can also use <code>.csv</code> file
input if preferred, with two columns headed “x” and “y”. We do not have
the original data table, nor do the original authors have access to it
anymore; but we can read the sequence of administered doses off of
Benhamou et al.’s Figure 1.</p>
<p>The figure sizes have been customised so that you can easily put two
images side-by-side.</p>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb1-1"><a href="#cb1-1" aria-hidden="true" tabindex="-1"></a><span class="co"># For brevity, we initially use integers to denote the doses. </span></span>
<span id="cb1-2"><a href="#cb1-2" aria-hidden="true" tabindex="-1"></a><span class="co"># We make use of R’s shorthand for consecutive sequences, </span></span>
<span id="cb1-3"><a href="#cb1-3" aria-hidden="true" tabindex="-1"></a><span class="co"># e.g., 1:3 is really 1,2,3</span></span>
<span id="cb1-4"><a href="#cb1-4" aria-hidden="true" tabindex="-1"></a>xropi <span class="ot">=</span> <span class="fu">c</span>(<span class="dv">11</span><span class="sc">:</span><span class="dv">9</span>,<span class="dv">10</span><span class="sc">:</span><span class="dv">8</span>,<span class="dv">9</span>,<span class="dv">10</span>,<span class="dv">9</span>,<span class="dv">10</span><span class="sc">:</span><span class="dv">7</span>,<span class="dv">8</span><span class="sc">:</span><span class="dv">11</span>,<span class="dv">10</span><span class="sc">:</span><span class="dv">12</span>,<span class="dv">11</span><span class="sc">:</span><span class="dv">7</span>,<span class="dv">8</span>,<span class="dv">7</span><span class="sc">:</span><span class="dv">10</span>,<span class="dv">9</span>,<span class="dv">8</span>,<span class="dv">9</span>,<span class="dv">8</span><span class="sc">:</span><span class="dv">10</span>,<span class="dv">9</span>,<span class="dv">10</span>,<span class="dv">9</span>,<span class="dv">10</span>)</span>
<span id="cb1-5"><a href="#cb1-5" aria-hidden="true" tabindex="-1"></a>xlevo <span class="ot">=</span> <span class="fu">c</span>(<span class="dv">11</span>,<span class="dv">10</span>,<span class="dv">11</span>,<span class="dv">10</span>,<span class="dv">11</span><span class="sc">:</span><span class="dv">9</span>,<span class="dv">10</span><span class="sc">:</span><span class="dv">7</span>,<span class="dv">8</span>,<span class="dv">7</span>,<span class="dv">8</span><span class="sc">:</span><span class="dv">5</span>,<span class="dv">6</span><span class="sc">:</span><span class="dv">8</span>,<span class="dv">7</span>,<span class="dv">8</span><span class="sc">:</span><span class="dv">6</span>,<span class="dv">7</span>,<span class="dv">6</span>,<span class="dv">7</span>,<span class="dv">6</span>,<span class="dv">7</span><span class="sc">:</span><span class="dv">5</span>,<span class="dv">6</span>,<span class="dv">7</span>,<span class="dv">6</span><span class="sc">:</span><span class="dv">12</span>)</span></code></pre></div>
<p>The study design being <em>“classical”</em> or median-finding UD, the
responses (<span class="math inline">\(y\)</span>) can be read off
directly from the doses (<span class="math inline">\(x\)</span>): a
positive increment indicates no effectiveness (<span class="math inline">\(y=0\)</span>), and vice versa. Symbolically, <span class="math display">\[y = \left( 1-diff(x) \right) / 2.\]</span> We use
this and the <code>DRtrace()</code> constructor utility, to create
objects that store doses (converted to their physical units) and
responses; as we call them here, the experimental “trace” or
<strong>trajectory.</strong></p>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb2-1"><a href="#cb2-1" aria-hidden="true" tabindex="-1"></a><span class="fu">library</span>(cir)</span>
<span id="cb2-2"><a href="#cb2-2" aria-hidden="true" tabindex="-1"></a>bhamou03ropi <span class="ot">=</span> <span class="fu">DRtrace</span>(<span class="at">x=</span>xropi[<span class="sc">-</span><span class="dv">40</span>]<span class="sc">/</span><span class="dv">100</span>, <span class="at">y=</span>(<span class="dv">1</span><span class="sc">-</span><span class="fu">diff</span>(xropi))<span class="sc">/</span><span class="dv">2</span>)</span>
<span id="cb2-3"><a href="#cb2-3" aria-hidden="true" tabindex="-1"></a>bhamou03levo <span class="ot">=</span> <span class="fu">DRtrace</span>(<span class="at">x=</span>xlevo[<span class="sc">-</span><span class="dv">40</span>]<span class="sc">/</span><span class="dv">100</span>, <span class="at">y=</span>(<span class="dv">1</span><span class="sc">-</span><span class="fu">diff</span>(xlevo))<span class="sc">/</span><span class="dv">2</span>)</span></code></pre></div>
<p>In the construction above, we gave up the 40th and last observation
in each arm, because we only know its dose but not the response.</p>
<p><code>DRtrace</code> objects have a native plotting method:</p>
<div class="sourceCode" id="cb3"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb3-1"><a href="#cb3-1" aria-hidden="true" tabindex="-1"></a><span class="fu">par</span>(<span class="at">mfrow=</span><span class="fu">c</span>(<span class="dv">1</span>,<span class="dv">2</span>), <span class="at">las=</span><span class="dv">1</span>, <span class="at">mar=</span><span class="fu">c</span>(<span class="dv">4</span>,<span class="dv">4</span>,<span class="dv">4</span>,<span class="dv">1</span>)) <span class="co"># image format parameters</span></span>
<span id="cb3-2"><a href="#cb3-2" aria-hidden="true" tabindex="-1"></a>doserange <span class="ot">=</span> <span class="fu">c</span>(<span class="dv">5</span>,<span class="dv">12</span>)<span class="sc">/</span><span class="dv">100</span></span>
<span id="cb3-3"><a href="#cb3-3" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb3-4"><a href="#cb3-4" aria-hidden="true" tabindex="-1"></a><span class="fu">plot</span>(bhamou03ropi, <span class="at">ylim=</span>doserange, <span class="at">ylab=</span><span class="st">&quot;Concentration (%)&quot;</span>, <span class="at">main=</span><span class="st">&#39;Ropivacaine Arm&#39;</span>)</span>
<span id="cb3-5"><a href="#cb3-5" aria-hidden="true" tabindex="-1"></a><span class="fu">legend</span>(<span class="st">&#39;bottomright&#39;</span>,<span class="at">legend=</span><span class="fu">c</span>(<span class="st">&#39;Effective&#39;</span>,<span class="st">&#39;Ineffective&#39;</span>),<span class="at">pch=</span><span class="fu">c</span>(<span class="dv">19</span>,<span class="dv">1</span>),<span class="at">bty=</span><span class="st">&#39;n&#39;</span>)</span>
<span id="cb3-6"><a href="#cb3-6" aria-hidden="true" tabindex="-1"></a><span class="fu">plot</span>(bhamou03levo, <span class="at">ylim=</span>doserange, <span class="at">ylab=</span><span class="st">&quot;Concentration (%)&quot;</span>, <span class="at">main=</span><span class="st">&#39;Levobupivacaine Arm&#39;</span>)</span></code></pre></div>
<p><img src="data:image/png;base64,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" width="800" height="400" /></p>
</div>
<div id="ed_50-estimates" class="section level2">
<h2>ED<span class="math inline">\(_{50}\)</span> Estimates</h2>
<p>To derive IR and CIR estimates, we take the <code>DRtrace</code>
trajectory objects and generate <code>doseResponse</code>
dose-rate-count summaries.</p>
<div class="sourceCode" id="cb4"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb4-1"><a href="#cb4-1" aria-hidden="true" tabindex="-1"></a>bhamou03ropiRates <span class="ot">=</span> <span class="fu">doseResponse</span>(bhamou03ropi)</span>
<span id="cb4-2"><a href="#cb4-2" aria-hidden="true" tabindex="-1"></a>bhamou03levoRates <span class="ot">=</span> <span class="fu">doseResponse</span>(bhamou03levo)</span>
<span id="cb4-3"><a href="#cb4-3" aria-hidden="true" tabindex="-1"></a>knitr<span class="sc">::</span><span class="fu">kable</span>(bhamou03ropiRates, <span class="at">row.names=</span><span class="cn">FALSE</span>,<span class="at">align=</span><span class="st">&#39;ccr&#39;</span>,<span class="at">digits=</span><span class="fu">c</span>(<span class="dv">2</span>,<span class="dv">4</span>,<span class="dv">0</span>))</span></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="center">x</th>
<th align="center">y</th>
<th align="right">weight</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="center">0.07</td>
<td align="center">0.0000</td>
<td align="right">3</td>
</tr>
<tr class="even">
<td align="center">0.08</td>
<td align="center">0.3750</td>
<td align="right">8</td>
</tr>
<tr class="odd">
<td align="center">0.09</td>
<td align="center">0.3846</td>
<td align="right">13</td>
</tr>
<tr class="even">
<td align="center">0.10</td>
<td align="center">0.8000</td>
<td align="right">10</td>
</tr>
<tr class="odd">
<td align="center">0.11</td>
<td align="center">0.7500</td>
<td align="right">4</td>
</tr>
<tr class="even">
<td align="center">0.12</td>
<td align="center">1.0000</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
<div class="sourceCode" id="cb5"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb5-1"><a href="#cb5-1" aria-hidden="true" tabindex="-1"></a>knitr<span class="sc">::</span><span class="fu">kable</span>(bhamou03levoRates, <span class="at">row.names=</span><span class="cn">FALSE</span>,<span class="at">align=</span><span class="st">&#39;ccr&#39;</span>,<span class="at">digits=</span><span class="fu">c</span>(<span class="dv">2</span>,<span class="dv">4</span>,<span class="dv">0</span>))</span></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="center">x</th>
<th align="center">y</th>
<th align="right">weight</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="center">0.05</td>
<td align="center">0.0000</td>
<td align="right">2</td>
</tr>
<tr class="even">
<td align="center">0.06</td>
<td align="center">0.2500</td>
<td align="right">8</td>
</tr>
<tr class="odd">
<td align="center">0.07</td>
<td align="center">0.5455</td>
<td align="right">11</td>
</tr>
<tr class="even">
<td align="center">0.08</td>
<td align="center">0.8333</td>
<td align="right">6</td>
</tr>
<tr class="odd">
<td align="center">0.09</td>
<td align="center">0.3333</td>
<td align="right">3</td>
</tr>
<tr class="even">
<td align="center">0.10</td>
<td align="center">0.4000</td>
<td align="right">5</td>
</tr>
<tr class="odd">
<td align="center">0.11</td>
<td align="center">0.7500</td>
<td align="right">4</td>
</tr>
</tbody>
</table>
<p>From here, ED<span class="math inline">\(_{50}\)</span> estimation is
one step away:</p>
<div class="sourceCode" id="cb6"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb6-1"><a href="#cb6-1" aria-hidden="true" tabindex="-1"></a>ropiTargetCIR<span class="ot">=</span><span class="fu">quickInverse</span>(bhamou03ropiRates, <span class="at">target=</span><span class="fl">0.5</span>, <span class="at">adaptiveShrink=</span><span class="cn">TRUE</span>)</span>
<span id="cb6-2"><a href="#cb6-2" aria-hidden="true" tabindex="-1"></a>ropiTargetCIR </span>
<span id="cb6-3"><a href="#cb6-3" aria-hidden="true" tabindex="-1"></a><span class="co">#   target      point lower90conf upper90conf</span></span>
<span id="cb6-4"><a href="#cb6-4" aria-hidden="true" tabindex="-1"></a><span class="co"># 1    0.5 0.09383622  0.08090006   0.1060014</span></span>
<span id="cb6-5"><a href="#cb6-5" aria-hidden="true" tabindex="-1"></a>levoTargetCIR<span class="ot">=</span><span class="fu">quickInverse</span>(bhamou03levoRates, <span class="at">target=</span><span class="fl">0.5</span>, <span class="at">adaptiveShrink=</span><span class="cn">TRUE</span>)</span>
<span id="cb6-6"><a href="#cb6-6" aria-hidden="true" tabindex="-1"></a>levoTargetCIR</span>
<span id="cb6-7"><a href="#cb6-7" aria-hidden="true" tabindex="-1"></a><span class="co">#   target      point lower90conf upper90conf</span></span>
<span id="cb6-8"><a href="#cb6-8" aria-hidden="true" tabindex="-1"></a><span class="co"># 1    0.5 0.06842105  0.05395897  0.08389953</span></span></code></pre></div>
<div id="notes" class="section level3">
<h3>Notes</h3>
<ul>
<li>The estimate appears under the word <code>point</code>: 0.0938% for
ropivacaine and 0.0684% for levobupivacaine.</li>
<li>We specify the target as a fraction, via the <code>target</code>
argument.</li>
<li>Default CIs are 90% rather than 95%, due to the large variabily in
these typical small-sample experiments. To change it use the
<code>conf</code> argument.</li>
<li>The <code>adaptiveShrink</code> option performs an empirical
correction the bias induced by the adaptive design, a bias discovered
and described recently by Flournoy and Oron.<a href="#fn5" class="footnote-ref" id="fnref5"><sup>5</sup></a> It is induced not just
by UD designs, but also by model-based designs such as the Continual
Reassessment Method. <strong>Because of this bias, we strongly recommend
to <em>not</em> estimate any target except 0.5 from these data, except
for exploratory/illustrative purposes.</strong> The correction serves
mostly to provide better CI coverage for the target dose estimate.</li>
<li>In an experiment with non-median targets such as the ED<span class="math inline">\(_{90}\)</span>, we recommend adding the option
<code>adaptiveCurve=TRUE</code> to the command above. This broadens the
confidence intervals a bit to ensure proper coverage, which is more
challenging the closer the target gets to the edge of the dose-response
curve.</li>
</ul>
<p>Let us calculate 83% CIs, to evaluate the evidence for different
potencies via the overlapping-intervals method.</p>
<div class="sourceCode" id="cb7"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb7-1"><a href="#cb7-1" aria-hidden="true" tabindex="-1"></a><span class="fu">quickInverse</span>(bhamou03ropiRates, <span class="at">target=</span><span class="fl">0.5</span>, <span class="at">adaptiveShrink=</span><span class="cn">TRUE</span>, <span class="at">conf=</span><span class="fl">0.83</span>)</span>
<span id="cb7-2"><a href="#cb7-2" aria-hidden="true" tabindex="-1"></a><span class="co">#   target      point lower83conf upper83conf</span></span>
<span id="cb7-3"><a href="#cb7-3" aria-hidden="true" tabindex="-1"></a><span class="co"># 1    0.5 0.09383622   0.0828185   0.1043032</span></span>
<span id="cb7-4"><a href="#cb7-4" aria-hidden="true" tabindex="-1"></a><span class="fu">quickInverse</span>(bhamou03levoRates, <span class="at">target=</span><span class="fl">0.5</span>, <span class="at">adaptiveShrink=</span><span class="cn">TRUE</span>, <span class="at">conf=</span><span class="fl">0.83</span>)</span>
<span id="cb7-5"><a href="#cb7-5" aria-hidden="true" tabindex="-1"></a><span class="co">#   target      point lower83conf upper83conf</span></span>
<span id="cb7-6"><a href="#cb7-6" aria-hidden="true" tabindex="-1"></a><span class="co"># 1    0.5 0.06842105  0.05602481  0.08173084</span></span></code></pre></div>
<p>The lower 83% confidence limit for ropivacaine’s ED<span class="math inline">\(_{50}\)</span> is almost touching the upper 83%
limit for levobupivacaine, but there’s no overlap. One may conclude that
there is moderate evidence for a difference in potency at the <span class="math inline">\(\alpha=0.05\)</span> level. Thus, our conclusion
is similar to Pace and Stylianou’s reanalysis, but not as strong. Our
point estimates are also very similar to theirs, and so is the levo/ropi
potency ratio (1.37, quite a bit higher than Benhamou et al.’s 1.19).
This should not be too surprising, because CIR is a direct upgrade of IR
which Pace and Stylianou used, whereas Benhamou et al. used dose
averaging.</p>
<p>Looking more closely for the source of discrepancy, the difference is
not in the ropivacaine estimates (0.092 vs. 0.093, and 0.094, by
Benhamou et al., Pace-Stylianou, and us, respectively) - but rather in
levobupivacaine (0.077, 0.068, 0.068). Looking even deeper, the
relatively high dose-avaeraging estimate for levobupivacaine in the
original article is mostly due to the experiment’s meandering (rather
than straight) path downward to the region where most of the doses were
given. There is reason to suspect that the starting-point effect was not
mitigated well enough. The original dose-averaging estimate probably
excluded only the first 1-2 doses. If one excludes, say, the first 10
doses, the average gets closer to IR/CIR (0.072), and the difference may
become significant.</p>
<p>Speaking of Pace and Stylianou’s point estimates, we can use the same
quickInverse() function to reproduce them:</p>
<div class="sourceCode" id="cb8"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb8-1"><a href="#cb8-1" aria-hidden="true" tabindex="-1"></a><span class="fu">quickInverse</span>(bhamou03ropiRates, <span class="at">target=</span><span class="fl">0.5</span>, <span class="at">estfun=</span>oldPAVA, <span class="at">conf=</span><span class="fl">0.83</span>)</span>
<span id="cb8-2"><a href="#cb8-2" aria-hidden="true" tabindex="-1"></a><span class="co">#   target      point lower83conf upper83conf</span></span>
<span id="cb8-3"><a href="#cb8-3" aria-hidden="true" tabindex="-1"></a><span class="co"># 1    0.5 0.09287671  0.08456467   0.1013001</span></span>
<span id="cb8-4"><a href="#cb8-4" aria-hidden="true" tabindex="-1"></a><span class="fu">quickInverse</span>(bhamou03levoRates, <span class="at">target=</span><span class="fl">0.5</span>, <span class="at">estfun=</span>oldPAVA, <span class="at">conf=</span><span class="fl">0.83</span>)</span>
<span id="cb8-5"><a href="#cb8-5" aria-hidden="true" tabindex="-1"></a><span class="co">#   target      point lower83conf upper83conf</span></span>
<span id="cb8-6"><a href="#cb8-6" aria-hidden="true" tabindex="-1"></a><span class="co"># 1    0.5 0.06846154  0.05851263   0.0796707</span></span></code></pre></div>
<p>Note the argument specifying the <code>oldPAVA()</code> estimation
function (PAVA is the name of the leading algorithm to produce IR
estimates; the package default is <code>cirPAVA()</code>, i.e.,
CIR).</p>
<p>Our confidence intervals are still different from Pace and
Stylianou’s, even when using the same point-estimation method. For
intervals they used the bootstrap, whereas we use an analytical approach
based on Morris’ theoretical work and the Delta method.<a href="#fn6" class="footnote-ref" id="fnref6"><sup>6</sup></a> Their levobupivacaine
83% CI is slightly wider than ours (0.059-0.081 vs. 0.059-0.080), but
their ropivacaine interval is substantially narrower (0.087-0.097
vs. 0.085-0.101). The latter is the more typical difference between the
two approaches. In fact, their ropivacaine 83% bootstrap CI is
unrealistically narrow given the amount of information in the
experiment, taking up only a single dose spacing (0.01).</p>
</div>
</div>
<div id="visualizing-on-the-dose-response-plane" class="section level2">
<h2>Visualizing on the Dose-Response Plane</h2>
<p>To construct the full estimated <span class="math inline">\(F(x)\)</span> curves from IR and CIR, we call
<code>cir</code>’s <em>“long-form”</em> forward-estimation
functions:</p>
<div class="sourceCode" id="cb9"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb9-1"><a href="#cb9-1" aria-hidden="true" tabindex="-1"></a>ropiCurveIR <span class="ot">=</span> <span class="fu">oldPAVA</span>(bhamou03ropiRates, <span class="at">full=</span><span class="cn">TRUE</span>)</span>
<span id="cb9-2"><a href="#cb9-2" aria-hidden="true" tabindex="-1"></a>ropiCurveCIR <span class="ot">=</span> <span class="fu">cirPAVA</span>(bhamou03ropiRates, <span class="at">target=</span><span class="fl">0.5</span>, <span class="at">adaptiveShrink=</span><span class="cn">TRUE</span>, <span class="at">full=</span><span class="cn">TRUE</span>)</span>
<span id="cb9-3"><a href="#cb9-3" aria-hidden="true" tabindex="-1"></a>levoCurveIR <span class="ot">=</span> <span class="fu">oldPAVA</span>(bhamou03levoRates, <span class="at">full=</span><span class="cn">TRUE</span>)</span>
<span id="cb9-4"><a href="#cb9-4" aria-hidden="true" tabindex="-1"></a>levoCurveCIR <span class="ot">=</span> <span class="fu">cirPAVA</span>(bhamou03levoRates, <span class="at">target=</span><span class="fl">0.5</span>, <span class="at">adaptiveShrink=</span><span class="cn">TRUE</span>, <span class="at">full=</span><span class="cn">TRUE</span>)</span></code></pre></div>
<p>Each of these returns a list of three <code>doseResponse</code>
objects. Here’s one of the lists:</p>
<div class="sourceCode" id="cb10"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb10-1"><a href="#cb10-1" aria-hidden="true" tabindex="-1"></a>ropiCurveCIR</span>
<span id="cb10-2"><a href="#cb10-2" aria-hidden="true" tabindex="-1"></a><span class="co"># $output</span></span>
<span id="cb10-3"><a href="#cb10-3" aria-hidden="true" tabindex="-1"></a><span class="co">#         x         y weight</span></span>
<span id="cb10-4"><a href="#cb10-4" aria-hidden="true" tabindex="-1"></a><span class="co"># 0.07 0.07 0.1250000      3</span></span>
<span id="cb10-5"><a href="#cb10-5" aria-hidden="true" tabindex="-1"></a><span class="co"># 0.08 0.08 0.3888889      8</span></span>
<span id="cb10-6"><a href="#cb10-6" aria-hidden="true" tabindex="-1"></a><span class="co"># 0.09 0.09 0.3928571     13</span></span>
<span id="cb10-7"><a href="#cb10-7" aria-hidden="true" tabindex="-1"></a><span class="co"># 0.1  0.10 0.6721501     10</span></span>
<span id="cb10-8"><a href="#cb10-8" aria-hidden="true" tabindex="-1"></a><span class="co"># 0.11 0.11 0.8553030      4</span></span>
<span id="cb10-9"><a href="#cb10-9" aria-hidden="true" tabindex="-1"></a><span class="co"># 0.12 0.12 1.0000000      1</span></span>
<span id="cb10-10"><a href="#cb10-10" aria-hidden="true" tabindex="-1"></a><span class="co"># </span></span>
<span id="cb10-11"><a href="#cb10-11" aria-hidden="true" tabindex="-1"></a><span class="co"># $input</span></span>
<span id="cb10-12"><a href="#cb10-12" aria-hidden="true" tabindex="-1"></a><span class="co">#         x         y weight</span></span>
<span id="cb10-13"><a href="#cb10-13" aria-hidden="true" tabindex="-1"></a><span class="co"># 0.07 0.07 0.1250000      3</span></span>
<span id="cb10-14"><a href="#cb10-14" aria-hidden="true" tabindex="-1"></a><span class="co"># 0.08 0.08 0.3888889      8</span></span>
<span id="cb10-15"><a href="#cb10-15" aria-hidden="true" tabindex="-1"></a><span class="co"># 0.09 0.09 0.3928571     13</span></span>
<span id="cb10-16"><a href="#cb10-16" aria-hidden="true" tabindex="-1"></a><span class="co"># 0.1  0.10 0.7727273     10</span></span>
<span id="cb10-17"><a href="#cb10-17" aria-hidden="true" tabindex="-1"></a><span class="co"># 0.11 0.11 0.7000000      4</span></span>
<span id="cb10-18"><a href="#cb10-18" aria-hidden="true" tabindex="-1"></a><span class="co"># 0.12 0.12 1.0000000      1</span></span>
<span id="cb10-19"><a href="#cb10-19" aria-hidden="true" tabindex="-1"></a><span class="co"># </span></span>
<span id="cb10-20"><a href="#cb10-20" aria-hidden="true" tabindex="-1"></a><span class="co"># $shrinkage</span></span>
<span id="cb10-21"><a href="#cb10-21" aria-hidden="true" tabindex="-1"></a><span class="co">#              x         y weight</span></span>
<span id="cb10-22"><a href="#cb10-22" aria-hidden="true" tabindex="-1"></a><span class="co"># 0.07 0.0700000 0.1250000      3</span></span>
<span id="cb10-23"><a href="#cb10-23" aria-hidden="true" tabindex="-1"></a><span class="co"># 0.08 0.0800000 0.3888889      8</span></span>
<span id="cb10-24"><a href="#cb10-24" aria-hidden="true" tabindex="-1"></a><span class="co"># 0.09 0.0900000 0.3928571     13</span></span>
<span id="cb10-25"><a href="#cb10-25" aria-hidden="true" tabindex="-1"></a><span class="co"># 0.1  0.1028571 0.7519480     14</span></span>
<span id="cb10-26"><a href="#cb10-26" aria-hidden="true" tabindex="-1"></a><span class="co"># 0.12 0.1200000 1.0000000      1</span></span></code></pre></div>
<p><code>$input</code> is the incoming data, <code>$output</code> the
estimates at the same doses, and <code>$shrinkage</code> the doses where
the algorithm makes the estimates (then interpolated to generate
<code>$output</code>). With <code>oldPAVA()</code> this will always be
identical to <code>$output</code>.</p>
<p><strong>Note:</strong> To obtain a quick, “short-form” forward
estimate – the forward analogue of <code>quickInverse()</code> used
above – use <code>quickIsotone()</code>. You will get an output similar
to the <code>$output</code> object, together with confidence intervals
for each dose. That function’s arguments are similar to
<code>quickInverse()</code>.</p>
<p>We end with the dose-response plots.</p>
<div class="sourceCode" id="cb11"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb11-1"><a href="#cb11-1" aria-hidden="true" tabindex="-1"></a><span class="fu">par</span>(<span class="at">mfrow=</span><span class="fu">c</span>(<span class="dv">1</span>,<span class="dv">2</span>), <span class="at">las=</span><span class="dv">1</span>, <span class="at">mar=</span><span class="fu">c</span>(<span class="dv">4</span>,<span class="dv">4</span>,<span class="dv">4</span>,<span class="dv">1</span>)) <span class="co"># image format parameters</span></span>
<span id="cb11-2"><a href="#cb11-2" aria-hidden="true" tabindex="-1"></a><span class="fu">plot</span>(bhamou03ropiRates, <span class="at">xlab=</span><span class="st">&quot;Concentration (%)&quot;</span>, </span>
<span id="cb11-3"><a href="#cb11-3" aria-hidden="true" tabindex="-1"></a><span class="at">ylab=</span><span class="st">&quot;Proportion Effective&quot;</span>, <span class="at">main=</span><span class="st">&#39;Ropivacaine Arm&#39;</span>)</span>
<span id="cb11-4"><a href="#cb11-4" aria-hidden="true" tabindex="-1"></a><span class="co"># Adding IR and CIR lines with the same colors/lines as article’s Fig. 4</span></span>
<span id="cb11-5"><a href="#cb11-5" aria-hidden="true" tabindex="-1"></a><span class="fu">lines</span>(y<span class="sc">~</span>x, <span class="at">data=</span>ropiCurveIR<span class="sc">$</span>output, <span class="at">lty=</span><span class="dv">2</span>)</span>
<span id="cb11-6"><a href="#cb11-6" aria-hidden="true" tabindex="-1"></a><span class="fu">lines</span>(y<span class="sc">~</span>x, <span class="at">data=</span>ropiCurveCIR<span class="sc">$</span>shrinkage, <span class="at">col=</span><span class="st">&#39;blue&#39;</span>,<span class="at">lwd=</span><span class="dv">2</span>)</span>
<span id="cb11-7"><a href="#cb11-7" aria-hidden="true" tabindex="-1"></a><span class="co"># Showing the CIR estimate, and confidence interval as a horizontal line</span></span>
<span id="cb11-8"><a href="#cb11-8" aria-hidden="true" tabindex="-1"></a><span class="fu">points</span>(target<span class="sc">~</span>point, <span class="at">data=</span>ropiTargetCIR, <span class="at">col=</span><span class="st">&#39;purple&#39;</span>, <span class="at">pch=</span><span class="dv">19</span>, <span class="at">cex=</span><span class="dv">2</span>)</span>
<span id="cb11-9"><a href="#cb11-9" aria-hidden="true" tabindex="-1"></a><span class="fu">lines</span>(<span class="fu">c</span>(ropiTargetCIR<span class="sc">$</span>lower90conf,ropiTargetCIR<span class="sc">$</span>upper90conf), <span class="fu">rep</span>(<span class="fl">0.5</span>,<span class="dv">2</span>), <span class="at">col=</span><span class="st">&#39;purple&#39;</span>, <span class="at">lwd=</span><span class="dv">2</span>)</span>
<span id="cb11-10"><a href="#cb11-10" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb11-11"><a href="#cb11-11" aria-hidden="true" tabindex="-1"></a><span class="co"># Adding legend:</span></span>
<span id="cb11-12"><a href="#cb11-12" aria-hidden="true" tabindex="-1"></a><span class="fu">legend</span>(<span class="st">&#39;bottomright&#39;</span>, <span class="at">legend=</span><span class="fu">c</span>(<span class="st">&quot;Observed Proportions&quot;</span>,<span class="st">&#39;Isotonic Regression&#39;</span>,</span>
<span id="cb11-13"><a href="#cb11-13" aria-hidden="true" tabindex="-1"></a>                              <span class="st">&#39;Centered Isotonic Regression&#39;</span>,<span class="st">&#39;Estimate +/- 90% CI&#39;</span>),</span>
<span id="cb11-14"><a href="#cb11-14" aria-hidden="true" tabindex="-1"></a>       <span class="at">bty=</span><span class="st">&#39;n&#39;</span>,<span class="at">pch=</span><span class="fu">c</span>(<span class="dv">4</span>,<span class="fu">rep</span>(<span class="cn">NA</span>,<span class="dv">2</span>),<span class="dv">16</span>),<span class="at">col=</span><span class="fu">c</span>(<span class="st">&#39;black&#39;</span>,<span class="st">&#39;black&#39;</span>,<span class="st">&#39;blue&#39;</span>,<span class="st">&#39;purple&#39;</span>),<span class="at">lty=</span><span class="fu">c</span>(<span class="dv">0</span>,<span class="dv">2</span>,<span class="dv">1</span>,<span class="dv">1</span>))</span>
<span id="cb11-15"><a href="#cb11-15" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb11-16"><a href="#cb11-16" aria-hidden="true" tabindex="-1"></a><span class="do">### Now, second plot for Levobupivacaine</span></span>
<span id="cb11-17"><a href="#cb11-17" aria-hidden="true" tabindex="-1"></a><span class="fu">plot</span>(bhamou03levoRates, <span class="at">xlab=</span><span class="st">&quot;Concentration (%)&quot;</span>, </span>
<span id="cb11-18"><a href="#cb11-18" aria-hidden="true" tabindex="-1"></a><span class="at">ylab=</span><span class="st">&quot;Proportion Effective&quot;</span>, <span class="at">main=</span><span class="st">&#39;Levobupivacaine Arm&#39;</span>, <span class="at">ylim=</span><span class="dv">0</span><span class="sc">:</span><span class="dv">1</span>)</span>
<span id="cb11-19"><a href="#cb11-19" aria-hidden="true" tabindex="-1"></a><span class="fu">lines</span>(y<span class="sc">~</span>x, <span class="at">data=</span>levoCurveIR<span class="sc">$</span>output, <span class="at">lty=</span><span class="dv">2</span>)</span>
<span id="cb11-20"><a href="#cb11-20" aria-hidden="true" tabindex="-1"></a><span class="fu">lines</span>(y<span class="sc">~</span>x, <span class="at">data=</span>levoCurveCIR<span class="sc">$</span>shrinkage, <span class="at">col=</span><span class="st">&#39;blue&#39;</span>,<span class="at">lwd=</span><span class="dv">2</span>)</span>
<span id="cb11-21"><a href="#cb11-21" aria-hidden="true" tabindex="-1"></a><span class="fu">points</span>(target<span class="sc">~</span>point, <span class="at">data=</span>levoTargetCIR, <span class="at">col=</span><span class="st">&#39;purple&#39;</span>, <span class="at">pch=</span><span class="dv">19</span>, <span class="at">cex=</span><span class="dv">2</span>)</span>
<span id="cb11-22"><a href="#cb11-22" aria-hidden="true" tabindex="-1"></a><span class="fu">lines</span>(<span class="fu">c</span>(levoTargetCIR<span class="sc">$</span>lower90conf,levoTargetCIR<span class="sc">$</span>upper90conf), <span class="fu">rep</span>(<span class="fl">0.5</span>,<span class="dv">2</span>), <span class="at">col=</span><span class="st">&#39;purple&#39;</span>, <span class="at">lwd=</span><span class="dv">2</span>)</span></code></pre></div>
<p><img src="data:image/png;base64,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" width="800" height="400" /></p>
<div id="notes-1" class="section level3">
<h3>Notes</h3>
<ul>
<li>The ‘x’ symbols showing the observed response rates come in varying
sizes: the area they occupy is proportional to the number of
observations. This is the <code>plot.doseResponse</code> default; to
change it use <code>varsize=FALSE</code>.</li>
<li>In this demonstration the CIR curves differ from the ordinary IR
curves not only in the CIR algorithm that “shrinks” horizontal intervals
to single points, but also in the bias correction. In principle this
correction is compatible with both methods, but here we applied it only
to CIR, because it did not exist at the time of Pace and Stylianou’s
article.</li>
</ul>
</div>
</div>
<div id="references" class="section level2">
<h2>References</h2>
</div>
<div class="footnotes footnotes-end-of-document">
<hr />
<ol>
<li id="fn1"><p>Benhamou D, Ghosh C, Mercier FJ. A Randomized Sequential
Allocation Study to Determine the Minimum Effective Analgesic
Concentration of Levobupivacaine and Ropivacaine in Patients Receiving
Epidural Analgesia for Labor. Anesthesiology. 2003;99(6):1383-1386.<a href="#fnref1" class="footnote-back">↩︎</a></p></li>
<li id="fn2"><p>Pace NL, Stylianou MP. Advances in and Limitations of
Up-and-down Methodology: A Précis of Clinical Use, Study Design, and
Dose Estimation in Anesthesia Research. Anesthesiology.
2007;107(1):144-152.<a href="#fnref2" class="footnote-back">↩︎</a></p></li>
<li id="fn3"><p>Oron AP, Flournoy N. Centered Isotonic Regression: Point
and Interval Estimation for Dose-Response Studies. Stat Biopharm Res.
2017;9(3):258-267.<a href="#fnref3" class="footnote-back">↩︎</a></p></li>
<li id="fn4"><p>Payton ME, Greenstone MH, Schenker N. Overlapping
confidence intervals or standard error intervals: What do they mean in
terms of statistical significance? J Insect Sci. 2003;3(1).<a href="#fnref4" class="footnote-back">↩︎</a></p></li>
<li id="fn5"><p>Flournoy N, Oron AP. Bias induced by adaptive
dose-finding designs. J Appl Stat. 2020;47(13-15):2431-2442.<a href="#fnref5" class="footnote-back">↩︎</a></p></li>
<li id="fn6"><p>Morris MD. Small-Sample Confidence Limits for Parameters
under Inequality Constraints with Application to Quantal Bioassay.
Biometrics. 1988;44:1083-1092.<a href="#fnref6" class="footnote-back">↩︎</a></p></li>
</ol>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
